- Acute Myeloid Leukaemia (AML): Preliminary Phase II clinical shows promising efficacy for bemcentinib in combo with low-intensity chemo in elderly AML patients unfit for intensive therapy- Non small cell lung cancer (NSCLC): Phase II clinical data continues to show promising clinical activity and improved overall survival, particularly in patients with AXL positive tumours including those with low or no PD-L1 expression.

WINDSOR LOCKS, Conn., Aug. 18, 2019 /PRNewswire/ -- Last weekend S.M.A.R.T. had a conference in Connecticut. https

KT-Ghana Deal Is First GEPP Service Outside Korea Ghana Will Upgrade Capacity to Handle Infectious Diseases KT Technologies Address Global Human Welfare Issues SEOUL, South Korea, Aug. 18, 2019 /PRNewswire/ -- KT Corp. (KRX: 030200; NYSE: KT) said its Global Epidemic Prevention Platform (

TAMPA, Fla., Aug. 16, 2019 /PRNewswire/ -- Link Home Care Services, cutting-edge LHCSA and CDPAP provider out of New York, selects Savii Inc. as their home care software platform. Their partnership formed due to shared values and desire to drive innovation in the home care industry.

ATLANTA, Aug. 16, 2019 /PRNewswire/ -- Today, the Gilead COMPASS (COMmitment to Partnership in Addressing HIV/AIDS in Southern States) Initiative®— announced a request for proposals (RFP) from organizations working to fight stigma, increase access to health services, and increase local leadership for

HOUSTON, Aug. 16, 2019 /PRNewswire/ -- Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced its financial results for the second quarter ended June 30, 2019. Additionally, th

ORLANDO, Fla., Aug. 16, 2019 /PRNewswire/ -- AllianceRx Walgreens Prime, one of the largest specialty and home delivery pharmacies in the country, has updated its list of limi

SILVER SPRING, Md., Aug. 16, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today approved the Barostim Neo System for the improvement of symptoms in patients with advanced heart failure who are not suited for treatment with other heart failure devices, such as cardiac resynchronization therapy. The FDA gave the device a

CHICAGO, Aug. 16, 2019 /PRNewswire/ -- For the first time in its 38-year history, Chicago-based AbelsonTaylor, one of the world's premier health and wellness advertising agencies, has a new president. Founder Dale Taylor announced today that Jeff Berg, formerly executive v

NEW YORK, Aug. 16, 2019 /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased sha